3-Bromo-6-chloro-2-fluoropyridine | CAS:885952-18-1

We serve 3-Bromo-6-chloro-2-fluoropyridine CAS:885952-18-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Bromo-6-chloro-2-fluoropyridine

Chemical Name:    3-Bromo-6-chloro-2-fluoropyridine
CAS.NO: 885952-18-1
Synonyms:3-BROMO-6-CHLORO-2-FLUOROPYRIDINE;
2-Bromo-6-fluoro-4-picoline;
Molecular Formula: C5H2BrClFN
Molecular Weight: 210.43100
 
Physical and Chemical Properties:
Density: 1.8±0.1 g/cm3
Melting point: /
Boiling point: 212.0±35.0 °C at 760 mmHg
Flash point: 82.0±25.9 °C
Index of Refraction: 1.555
 
Specification:
Appearance: White Crystalline Powder
Purity:≥99.0%
 
Packing:25 KGS/Drum
Storage:Store in a tightly closed container. Store in a cool, dry
Application:   used in the Pharmaceutical intermediate



Contact us for information like 3-Bromo-6-chloro-2-fluoropyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Bromo-6-fluoro-4-picoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-BROMO-6-CHLORO-2-FLUOROPYRIDINE Use and application,3-BROMO-6-CHLORO-2-FLUOROPYRIDINE technical grade,usp/ep/jp grade.


Related News: Dr Maria Van Kerkhove, of the WHO’s emerging diseases unit, says it is important that you keep up basic hand and respiratory hygiene, such as washing your hands with soap and water and sneezing into your elbow or a tissue.1,1-Cyclohexanediacetic acid manufacturer Dr Maria Van Kerkhove, of the WHO’s emerging diseases unit, says it is important that you keep up basic hand and respiratory hygiene, such as washing your hands with soap and water and sneezing into your elbow or a tissue.3,6-Dichloropyridazine supplier At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.O-[(Ethoxycarbonyl)cyanomethyleneamino]-N,N,N',N'-tetramethyluronium Tetrafluoroborate vendor Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.But now, the metropolis of 11 million in Hubei province has become the face of a deadly coronavirus outbreak — a stigma the people of Wuhan increasingly find themselves unable to shake off.